These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31582399)

  • 1. Vitamin D enhances responses to interferon-β in MS.
    Feng X; Wang Z; Howlett-Prieto Q; Einhorn N; Causevic S; Reder AT
    Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):e622. PubMed ID: 31582399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
    Feng X; Petraglia AL; Chen M; Byskosh PV; Boos MD; Reder AT
    J Neuroimmunol; 2002 Aug; 129(1-2):205-15. PubMed ID: 12161037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins.
    Feng X; Han D; Kilaru BK; Franek BS; Niewold TB; Reder AT
    Arch Neurol; 2012 Oct; 69(10):1303-9. PubMed ID: 22801747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.
    Hussien Y; Sanna A; Söderström M; Link H; Huang YM
    Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.
    Tanasescu R; Midgley A; Robins RA; Constantinescu CS
    Acta Neurol Scand; 2017 Sep; 136(3):233-238. PubMed ID: 27918083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive markers for response to interferon therapy in patients with multiple sclerosis.
    Malucchi S; Gilli F; Caldano M; Marnetto F; Valentino P; Granieri L; Sala A; Capobianco M; Bertolotto A
    Neurology; 2008 Mar; 70(13 Pt 2):1119-27. PubMed ID: 18272865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse Relation between MxA Gene Expression and Age in Multiple Sclerosis Patients Reveals a Gender Difference in Response to Interferon Therapy.
    Taheri M; Mirinezhad M; Omrani MD; Sajjadi E; Inoko H; Sayad A
    Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):21-27. PubMed ID: 28417621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment.
    Ozenci V; Kouwenhoven M; Huang YM; Xiao B; Kivisäkk P; Fredrikson S; Link H
    Scand J Immunol; 1999 May; 49(5):554-61. PubMed ID: 10320650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
    Haghikia A; Faissner S; Pappas D; Pula B; Akkad DA; Arning L; Ruhrmann S; Duscha A; Gold R; Baranzini SE; Malhotra S; Montalban X; Comabella M; Chan A
    Mult Scler; 2015 Sep; 21(10):1262-70. PubMed ID: 25480861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.
    Sarchielli P; Critelli A; Greco L; Sokola E; Floridi A; Gallai V
    Cytokine; 2001 Jun; 14(5):294-8. PubMed ID: 11444910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergetic and antagonistic effects of combined calcitriol and interferon-β treatment on cytokine production by stimulated PBMCs.
    Simpson S; Stewart N; van der Mei I; Blizzard L; Taylor BV
    J Neuroimmunol; 2016 Aug; 297():148-55. PubMed ID: 27397088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-beta1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression.
    Reder AT; Velichko S; Yamaguchi KD; Hamamcioglu K; Ku K; Beekman J; Wagner TC; Perez HD; Salamon H; Croze E
    J Interferon Cytokine Res; 2008 May; 28(5):317-31. PubMed ID: 18547162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
    Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
    J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis.
    Byskosh PV; Reder AT
    Mult Scler; 1996 Apr; 1(5):262-9. PubMed ID: 9345428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.
    Lalive PH; Kantengwa S; Benkhoucha M; Juillard C; Chofflon M
    J Neuroimmunol; 2008 Jul; 197(2):147-51. PubMed ID: 18555540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis: deficient in vitro responses of blood mononuclear cells to IFN-beta.
    Huang YM; Hussien Y; Jin YP; Söderstrom M; Link H
    Acta Neurol Scand; 2001 Nov; 104(5):249-56. PubMed ID: 11696016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
    Stewart N; Simpson S; van der Mei I; Ponsonby AL; Blizzard L; Dwyer T; Pittas F; Eyles D; Ko P; Taylor BV
    Neurology; 2012 Jul; 79(3):254-60. PubMed ID: 22700816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.
    Genç K; Dona DL; Reder AT
    J Clin Invest; 1997 Jun; 99(11):2664-71. PubMed ID: 9169496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.